Displaying 37 - 48 of 74
Cirrhosis & Complications
1

Sobi: When Platelet Count Matters: Prophylaxis Ahead of Procedures in Chronic Liver Disease Patients (CLD) - ILC 2021

View
Metabolism, Alcohol & Toxicity
1

Bristol Myers Squibb: NASH: An evolution in treatment response tools - ILC 2021

View
Viral Hepatitis
6

AbbVie: The Road to HCV Elimination: Always Forward - ILC 2021

View
Viral Hepatitis
6

AbbVie: The Road to HCV Elimination: Always Forward - ILC 2021

View
Viral Hepatitis
6

AbbVie: The Road to HCV Elimination: Always Forward - ILC 2021

View
Viral Hepatitis
6

AbbVie: The Road to HCV Elimination: Always Forward - ILC 2021

View
Viral Hepatitis
6

AbbVie: The Road to HCV Elimination: Always Forward - ILC 2021

View
Viral Hepatitis
6

AbbVie: The Road to HCV Elimination: Always Forward - ILC 2021

View
Metabolism, Alcohol & Toxicity
5

Novo Nordisk: Unmasking NASH: the hepatic face of metabolic dysregulation - ILC 2021

View
Metabolism, Alcohol & Toxicity
5

Novo Nordisk: Unmasking NASH: the hepatic face of metabolic dysregulation - ILC 2021

View
Metabolism, Alcohol & Toxicity
5

Novo Nordisk: Unmasking NASH: the hepatic face of metabolic dysregulation - ILC 2021

View
Metabolism, Alcohol & Toxicity
5

Novo Nordisk: Unmasking NASH: the hepatic face of metabolic dysregulation - ILC 2021

View
Displaying 37 - 48 of 74